Monte Rosa Therapeutics, Inc. (GLUE) reported Q2 Revenue
Tweet
Share
E-mailGet Alerts GLUE Hot Sheet
Join SI Premium – FREE
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) reported Q2 Revenue for the quarter came in at $23.19 million versus the consensus estimate of $6.33 million.
For earnings history and earnings-related data on Monte Rosa Therapeutics, Inc. (GLUE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA says convenience store sales trail broader retail channels
- Lowe's Cos. (LOW) call put ratio 1.7 calls to 1 put into quarter results
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
